Mr David Jones BSc, MSc, EurBiol, CBiol, FRSB, ERT, FBTS

Nonclinical Lead

David Jones can support your innovation from a nonclinical perspective. With 25 years experience assessing clinical trial and license applications at MHRA, David is ideally positioned to advise on what it takes to move your innovation into the clinic or likely questions from Regulators on your nonclinical data package.

David was MHRA’s most senior nonclinical assessor in 2021 and served as an assessor for 25 years. David is a European Registered Toxicologist and a Fellow of the British Toxicology Society, as well as a Fellow of the Royal Society of Biology.

David has over 45 years’ experience as a Toxicologist, both in the pharmaceutical industry and as a Regulator. In his 25 years at the MHRA, the UK’s Regulatory Agency, he was responsible for assessing the nonclinical data for Clinical Trial Authorisation Applications and Marketing Authorisation Applications. He also chaired over a hundred scientific advice meetings every year on behalf of the Agency’s Clinical Trials Unit. David represented the MHRA in a number of working parties, including the Safety Working Party and the nonclinical group supporting the Paediatric Committee. David represented the EU at ICH for many years and has contributed into shaping international Safety guidelines.

Highly experienced with vaccine trial assessment
Former member of the Nonclinical Working Group supporting the EU Paediatric Committee
Experience of MHRA-FDA paediatric and oncology projects
Experienced with EU Clinical Trials Facilitation Group and support of drafting of EU CTR 2014/536

Advancement of Life-Changing Therapeutic Medicines for Rare Disease

Contact

Feel free to reach out if you want to collaborate with us, or simply chat.